BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 26774024)

  • 1. TGF-β Signaling in Cancer.
    Syed V
    J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring anti-TGF-β therapies in cancer and fibrosis.
    Hawinkels LJ; Ten Dijke P
    Growth Factors; 2011 Aug; 29(4):140-52. PubMed ID: 21718111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF- β: an important mediator of allergic disease and a molecule with dual activity in cancer development.
    Tirado-Rodriguez B; Ortega E; Segura-Medina P; Huerta-Yepez S
    J Immunol Res; 2014; 2014():318481. PubMed ID: 25110717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta signaling in cancer invasion and metastasis.
    Leivonen SK; Kähäri VM
    Int J Cancer; 2007 Nov; 121(10):2119-24. PubMed ID: 17849476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β signaling in cancer.
    Gu S; Feng XH
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):941-949. PubMed ID: 30165534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta in cancer and metastasis.
    Jakowlew SB
    Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
    Pardali K; Moustakas A
    Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
    Park CY; Kim DK; Sheen YY
    Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad phospho-isoforms direct context-dependent TGF-β signaling.
    Matsuzaki K
    Cytokine Growth Factor Rev; 2013 Aug; 24(4):385-99. PubMed ID: 23871609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSC1 activates TGF-β-Smad2/3 signaling in growth arrest and epithelial-to-mesenchymal transition.
    Thien A; Prentzell MT; Holzwarth B; Kläsener K; Kuper I; Boehlke C; Sonntag AG; Ruf S; Maerz L; Nitschke R; Grellscheid SN; Reth M; Walz G; Baumeister R; Neumann-Haefelin E; Thedieck K
    Dev Cell; 2015 Mar; 32(5):617-30. PubMed ID: 25727005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative modeling and analysis of the transforming growth factor beta signaling pathway.
    Chung SW; Miles FL; Sikes RA; Cooper CR; Farach-Carson MC; Ogunnaike BA
    Biophys J; 2009 Mar; 96(5):1733-50. PubMed ID: 19254534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta signaling in cancer.
    Rich J; Borton A; Wang X
    Microsc Res Tech; 2001 Feb; 52(4):363-73. PubMed ID: 11170295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta signaling in cancer treatment.
    Fabregat I; Fernando J; Mainez J; Sancho P
    Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor β signaling pathway: A promising therapeutic target for cancer.
    Chen Y; Di C; Zhang X; Wang J; Wang F; Yan JF; Xu C; Zhang J; Zhang Q; Li H; Yang H; Zhang H
    J Cell Physiol; 2020 Mar; 235(3):1903-1914. PubMed ID: 31332789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
    Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
    Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.